NOVOZYMES A/S SPONS.ADR 1 (NZM) — Net Asset Quality Index
NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Net Asset Quality Index of 66.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €16.52 Billion minus total liabilities of €5.60 Billion yields net assets of €10.92 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check NOVOZYMES A/S SPONS.ADR 1 (NZM) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
NOVOZYMES A/S SPONS.ADR 1 Net Asset Quality Index Over Time (2021–2025)
This chart shows how NOVOZYMES A/S SPONS.ADR 1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 66.1%, representing net assets of €10.92 Billion against total assets of €16.52 Billion EUR. See NOVOZYMES A/S SPONS.ADR 1 (NZM) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see NOVOZYMES A/S SPONS.ADR 1 (NZM) market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.4% | €10.86 Billion | €16.35 Billion | €5.49 Billion | ▼ -7.2 pp |
| 2024 | 73.5% | €11.18 Billion | €15.20 Billion | €4.02 Billion | ▲ +23.0 pp |
| 2023 | 50.5% | €1.93 Billion | €3.81 Billion | €1.88 Billion | ▼ -0.3 pp |
| 2022 | 50.8% | €1.91 Billion | €3.76 Billion | €1.85 Billion | ▲ +1.6 pp |
| 2021 | 49.3% | €1.64 Billion | €3.33 Billion | €1.69 Billion | — |